首页> 外文期刊>Tropical Journal of Pharmaceutical Research >In vivo Evaluation of Amoxicillin Trihydrate and Clarithromycin-Loaded Mucoadhesive Microspheres for H. pylori Eradication
【24h】

In vivo Evaluation of Amoxicillin Trihydrate and Clarithromycin-Loaded Mucoadhesive Microspheres for H. pylori Eradication

机译:体内评估阿莫西林三水合物和克拉霉素负载的粘膜黏附微球对幽门螺杆菌的根除

获取原文
           

摘要

Purpose: To evaluate in vivo H. pylori clearance efficacy of formulated mucoadhesive microspheres of amoxicillin trihydrate and clarithromycin. Methods: Amoxicillin trihydrate and clarithromycin mucoadhesive microspheres were prepared by solvent evaporation method using Carbopol 974P, HPMC K4M and Eudragit RS 100. In vivo clearance efficacy of the microspheres was evaluated in a Wistar rat model after induction of H. pylori infection. Amoxicillin and clarithromycin-loaded microspheres were administered twice daily for three days. H. pylori clearance was evaluated by assessing colony count. Results: Treatment with plain drug solution (90 mg/kg amoxicillin and 45 mg/kg clarithromycin) resulted in a colony count of log 1.25 ± 0.56 CFU and clearance rate of 60 %, while mucoadhesive microspheres-loaded dose of 45 mg/kg amoxicillin and 22.5 mg/kg clarithromycin resulted in complete (100 %) eradication of H. pylori infection. Conclusion: The developed mucoadhesive amoxicillin/clarithromycin microspheres can potentially be used to effectively eradicate H. pylori infection.
机译:目的:评估配制的三水阿莫西林和克拉霉素的粘膜粘附微球的体内幽门螺杆菌清除效果。方法:采用溶剂蒸发法,用Carbopol 974P,HPMC K4M和Eudragit RS 100制备三水合阿莫西林和克拉霉素粘膜粘附微球。在幽门螺杆菌感染诱导后的Wistar大鼠模型中评估微球的体内清除效果。阿莫西林和克拉霉素微球每日两次,持续三天。通过评估菌落计数来评估幽门螺杆菌清除率。结果:用普通药物溶液(90 mg / kg阿莫西林和45 mg / kg克拉霉素)处理后,菌落计数为log 1.25±0.56 CFU,清除率为60%,而粘膜黏附微球负载剂量为45 mg / kg阿莫西林和22.5 mg / kg克拉霉素可彻底根除(100%)幽门螺杆菌感染。结论:发达的粘膜粘附性阿莫西林/克拉霉素微球可潜在地有效根除幽门螺杆菌感染。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号